Assessing hs-Troponin T and NT-proBNP in acute heart failure and cardiorenal syndrome: Diagnostic, prognostic, and functional interrelationships

1 Suchina J, Lüthi-Corridori G, Jaun F, Leuppi JD, Boesing M. Diagnosis and Treatment of Acute Heart Failure: A Retrospective Observational Study and Medical Audit. Journal of Clinical Medicine. 2024;13(19):5951. Search in Google Scholar

2 Abd Alredha RD, Farman HA. Plasma L-FABP as a superior biomarker for detecting and characterizing cardiorenal syndrome in acute heart failure: comparative insights with hs-troponin T and NT-proBNP. Anaesthesia, Pain & Intensive Care. 2025;29(2):284-293. Search in Google Scholar

3 Tanwar P, Naagar M, Malik G, et al. Relationship between right heart failure and cardio-renal syndrome: A review. 2023. Search in Google Scholar

4 Desai R, Damarlapally N, Bareja S, et al. A systematic review and meta-analysis evaluating the association of high sensitivity troponin levels with outcomes in patients with stable coronary artery disease. Current Medical Research and Opinion. 2024;40(10):1685-1695. Search in Google Scholar

5 Rosół N, Procyk G, Kacperczyk-Bartnik J, Grabowski M, Gąsecka A. N-terminal prohormone of brain natriuretic peptide in gestational hypertension and preeclampsia–State of the art. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2024; Search in Google Scholar

6 Christodorescu RM, Brie DM, Brie AD, et al. Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels. Diagnostics. 2024;14(22):2507. Search in Google Scholar

7 Faraj HR. Serum NT-pro BNP and Other Biochemical Markers in Patients with Cardiorenal Syndrome (CRS) in Thi-Qar province-Iraq. Journal of Bioscience and Applied Research. 2024;10(4):686-694. Search in Google Scholar

8 Gürgöze MT, Van Vark LC, Baart SJ, et al. Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, creatinine, and prognosis in acute heart failure. Circulation: Heart Failure. 2023;16(1):e009526. Search in Google Scholar

9 Koechlin L, Boeddinghaus J, Lopez-Ayala P, et al. Performance of high-sensitivity cardiac troponin T versus I for the early diagnosis of myocardial infarction. European Heart Journal. 2022;43(Supplement_2):ehac544. 1339. Search in Google Scholar

10 Segre CAW, De Lemos JA, Junior ANA, et al. Chronic troponin elevation assessed by myocardial T1 mapping in patients with stable coronary artery disease. Medicine. 2023;102(16):e33548. Search in Google Scholar

11 Chaulin AM. The importance of cardiac troponin metabolism in the laboratory diagnosis of myocardial infarction (comprehensive review). BioMed Research International. 2022;2022(1):6454467. Search in Google Scholar

12 Maayah M, Grubman S, Allen S, et al. Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing. Diagnostics. 2024;14(5):503. Search in Google Scholar

13 Chaikijurajai T, Demirjian S, Tang WW. Prognostic Value of Natriuretic Peptide Levels for Adverse Renal Outcomes in Patients With Moderate to Severe Acute Kidney Injury With or Without Heart Failure. Journal of the American Heart Association. 2023;12(21):e031453. Search in Google Scholar

14 Idris I. Four biomarkers shown to predict the risk of progressive heart and kidney disease in people with type 2 diabetes with diabetic kidney disease. Wiley Online Library; 2023. Search in Google Scholar

15 Kula A, Bansal N. Applications of cardiac biomarkers in chronic kidney disease. Current opinion in nephrology and hypertension. 2022;31(6):534-540. d Search in Google Scholar

16 Zhang S, Wang Y, Song D, et al. Nanopore discrimination and sensitive plasma detection of multiple natriuretic peptides: The representative biomarker of human heart failure. Biosensors and Bioelectronics. 2023;231:115299. Search in Google Scholar

17 Roos A, Edgren G, Holzmann MJ. Temporal Changes of Stable High-Sensitivity Cardiac Troponin T Levels and Prognosis. Journal of the American Heart Association. 2022;11(11):e025082. Search in Google Scholar

18 Penda S, DZUDIE A, Fouda H, Ebene R, Halle MP. NT-proBNP: A Potential Diagnostic Tool for Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease in a Tertiary Hospital In Sub-Saharan Africa. Circulation. 2024;150(Suppl_1):A4146586-A4146586. Search in Google Scholar

19 Neuen B, Vaduganathan M, Claggett B, et al. Natriuretic peptides, kidney function and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: pooled data from the I-PRESERVE, TOPCAT, PARAGON and DELIVER trials. European Heart Journal. 2024;45(Supplement_1):ehae666. 786. Search in Google Scholar

20 Run-Qing J, Bin W, Zhang J-G, et al. Independent prognostic value of the congestion and renal index in patients with acute heart failure. Journal of Geriatric Cardiology: JGC. 2023;20(7):516. Search in Google Scholar

21 Carubelli V, Metra M, Lombardi C, et al. Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. Heart failure reviews. 2012;17:271-282. Search in Google Scholar

22 Mitsas AC, Elzawawi M, Mavrogeni S, et al. Heart failure and cardiorenal syndrome: a narrative review on pathophysiology, diagnostic and therapeutic regimens—from a cardiologist’s view. Journal of Clinical Medicine. 2022;11(23):7041. Search in Google Scholar

23 Baumgartner H, De Backer J. The ESC clinical practice guidelines for the management of adult congenital heart disease 2020. Oxford University Press; 2020. Search in Google Scholar

24 Aletras G, Stratinaki M, Eleftheriadou E, et al. Acute cardiorenal syndrome: baseline comorbidities, biomarkers and prognostic significance. European Journal of Preventive Cardiology. 2024;31(Supplement_1):zwae175.043. Search in Google Scholar

25 McCallum W, Sarnak MJ. Cardiorenal syndrome in the hospital. Clinical Journal of the American Society of Nephrology. 2023;18(7):933-945. Search in Google Scholar

26 Shrestha B, Dunn L. The declaration of Helsinki on medical research involving human subjects: a review of seventh revision. 2019. Search in Google Scholar

27 Inker LA, Eneanya ND, Coresh J, et al. New creatinine-and cystatin C– based equations to estimate GFR without race. New England Journal of Medicine. 2021;385(19):1737-1749. Search in Google Scholar

28 Markovic M, Kragholm K, Torp-Pedersen C, Pareek M. High-sensitivity troponin T and risk of stroke in persons with suspected acute coronary syndrome. European Heart Journal. 2024;45(Supplement_1):ehae666. 1607. Search in Google Scholar

29 Hammerer-Lercher A, Maria B, Wussler D, et al. A-018 Diagnostic Performance of the Novel Beckman-Coulter NT-proBNP-assay in the Early Diagnosis of Acute Heart Failure. Clinical Chemistry. 2024;70(Supplement_1):hvae106. 018. Search in Google Scholar

30 Zydzik L, Dadanski E, Tyjas K, et al. Comparison of left ventricular volumes and ejection fraction values between echocardiography and cardiac magnetic resonance: a pilot study. Journal of Hypertension. 2024;42(Suppl 1):e147. Search in Google Scholar

31 George D, Mallery P. IBM SPSS statistics 26 step by step: A simple guide and reference. Routledge; 2019. Search in Google Scholar

32 Shende P, Reddy A, Vikhe VB, Patil RS, Faruqi AA, Khandol D. A Study of Abnormal Echocardiogram Findings in Patients With Chronic Kidney Disease With Reference to Cardiac Biomarkers. Cureus. 2024;16(7):e65398. Search in Google Scholar

33 Landler NE, Olsen FJ, Christensen J, et al. Associations between albuminuria, estimated GFR and cardiac phenotype in a cohort with chronic kidney disease: the CPH-CKD ECHO study. Journal of Cardiac Failure. 2022;28(11):1615-1627. Search in Google Scholar

34 Sobue Y, Watanabe E, Funato Y, Yanase M, Izawa H. Renal dysfunction is a time-varying risk predictor of sudden cardiac death in heart failure. ESC Heart Failure. 2024; Search in Google Scholar

35 Horiuchi Y, Wettersten N, van Veldhuisen DJ, et al. Potential utility of cardiorenal biomarkers for prediction and prognostication of worsening renal function in acute heart failure. Journal of cardiac failure. 2021;27(5):533-541. Search in Google Scholar

36 Sciaccaluga C, Ghionzoli N, Mandoli GE, et al. Biomarkers in patients with left ventricular assist device: An insight on current evidence. Biomolecules. 2022;12(2):334. Search in Google Scholar

37 Chen R, Pang M, Yu H, et al. Kidney function–specific cut-off values of high-sensitivity cardiac troponin T for the diagnosis of acute myocardial infarction. Clinical Kidney Journal. 2024;17(9):sfae247. Search in Google Scholar

38 Ruocco G, Palazzuoli A, Ter Maaten JM. The role of the kidney in acute and chronic heart failure. Heart failure reviews. 2020;25:107-118. Search in Google Scholar

39 da Costa T, da Costa Machado E, de Barros LAAC, et al. Heart Failure and Chronic Kidney Disease: Prognosis and Therapeutic and Surgical Options. Brazilian Journal of Implantology and Health Sciences. 2024;6(8):1119-1132. Search in Google Scholar

40 Kristensen JH, Hasselbalch RB, Strandkjær N, et al. Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans. Circulation. 2024;150(15):1187-1198. Search in Google Scholar

41 Choi Y, Lee JH. Clinical usefulness of NT-proBNP as a prognostic factor for septic shock patients presenting to the emergency department. Scientific Reports. 2024;14(1):10999. Search in Google Scholar

42 Dri E, Lampas E, Lazaros G, et al. Inflammatory mediators of endothelial dysfunction. Life. 2023;13(6):1420. Search in Google Scholar

43 Song J-S, Cao C, Li H-R, Li L, Liu J-X. Mechanisms of oxidative stress in myocardial ischemia-reperfusion injury and protective effects of traditional Chinese medicines. Zhongguo Zhong yao za zhi= Zhongguo Zhongyao Zazhi= China Journal of Chinese Materia Medica. 2024;49(13):3452-3461. Search in Google Scholar

44 Zhao X, Han D, Zhao C, et al. New insights into the role of Klotho in inflammation and fibrosis: molecular and cellular mechanisms. Frontiers in Immunology. 2024;15:1454142. Search in Google Scholar

45 Akhabue E, Wong M, Mehta R, et al. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study. American heart journal. 2022;245:10-18. Search in Google Scholar

46 Frangogiannis NG. TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities. Expert Opinion on Therapeutic Targets. 2024;28(1-2):45-56. Search in Google Scholar

47 Jackson JW, Streich Jr FC, Pal A, et al. An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Science Signaling. 2024;17(844):eadn6052. Search in Google Scholar